![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, March 15, 2015 12:43:15 PM
As I previously posted, all the options held by insiders are at an exercise price of eight cents or higher. Also any of the four products currently in the pipeline (many more than four with the various orphan indications for MANF) have the potential to be worth many times Amarantus' current market cap.
When thinking of selling a stock which I own at a higher price I ask myself if I didn't own the stock and had just heard about it would I be buying it here. If the answer is yes then I certainly wouldn't sell and in fact would be adding shares as I have been doing.
Amarantus is undervalued and is still unknown to the market at large.
I believe that by the end of the week we'll have a much better idea of Gerald's business plan for 2015.
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM